Table 2 The efficacy of chemotherapy in patients with ED-SCLC without or with IP (n = 161)
Without IP | With IP, | |
|---|---|---|
n = 130 | n = 31 | |
Response to initial chemotherapy, n (%) | ||
Partial response | 80 (61.5) | 20 (64.5) |
Stable disease | 20 (15.4) | 6 (19.4) |
Progressive Disease | 17 (13.1) | 2 (6.4) |
Not evaluated | 13 (10.0) | 3 (9.7) |
Number of chemotherapy, n (%) | ||
1 | 53 (40.8) | 20 (64.5) |
2 | 46 (35.4) | 10 (32.3) |
≥3 | 31 (23.8) | 1 (3.2) |
Regimen of initial chemotherapy, n (%) | ||
CDDP + CPT | 17 (13.1) | 0 (0) |
CDDP + ETP | 5 (3.8) | 6 (19.4) |
CBDCA + CPT | 4 (3.1) | 0 (0) |
CBDCA + ETP | 35 (26.9) | 21 (67.7) |
AMR | 69 (53.1) | 4 (12.9) |